NCT00211926View on ClinicalTrials.gov

StaphVAX Immunogenicity in Orthopedic Implant Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

October 31, 2006

Conditions
Staphylococcal InfectionsJoint Prosthesis
Interventions
BIOLOGICAL

S. aureus Type 5 & 8 Capsular Polysaccharide Conjugate

single dose of vaccine containing 100 mcg of each serotype conjugate

BIOLOGICAL

placebo

single dose of placebo

Trial Locations (1)

23507

Cllinical Research Asociates of Tidewater, Norfolk

Sponsors
All Listed Sponsors
lead

Nabi Biopharmaceuticals

INDUSTRY

NCT00211926 - StaphVAX Immunogenicity in Orthopedic Implant Patients | Biotech Hunter | Biotech Hunter